1. Eyler RF, Shvets K. Clinical Pharmacology of Antibiotics. CJASN. 2019;14:1080–1090 doi: https://doi.org/10.2215/CJN.08140718
3. MIMS. Drug Information: Dicloxacillin. 2021. https://www.mims.com/indonesia/drug/info/dicloxacillin?mtype=generic
4. National Center for Biotechnology Information. PubChem Compound Summary for CID 18381, Dicloxacillin. https://pubchem.ncbi.nlm.nih.gov/compound/Dicloxacillin. Accessed Aug. 18, 2021.
5. Medscape. Drug and Diseases: Dicloxacillin. 2021. https://reference.medscape.com/drug/dicloxacillin-342477#0
6. Nissen JL, Skov R, Knudsen JD, et al. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case–control and cohort analysis. J Antimicrob Chemother 2013; 68: 1894 –1900 doi:10.1093/jac/dkt108
8. Yu W, Ji J, Xiao T, et al. Determining optimal dosing regimen of oral administration of dicloxacillin using Monte Carlo simulation. Drug Design, Development and Therapy. 2017;11: 1951–1956 http://dx.doi.org/10.2147/DDDT.S139632
9. Rasmussen JB, Knudsen JD, Arpi M, et al. Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study. J Antimicrob Chemother. 2014; 69: 506 –514 doi:10.1093/jac/dkt375
11. Stage TB, Graff M, Wong S, et al. Drug Metabolism Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro. Br J Clin Pharmacol. 2018; 84: 510–519 DOI:10.1111/bcp.13467
12. Golan Y. Current Treatment Options for Acute Skin and Skin-structure Infections. Clin Infect Dis. 2019;68(Suppl 3):S206-S212. doi:10.1093/cid/ciz004
13. Drugs. Dicloxacillin dosage. 2020. https://www.drugs.com/dosage/dicloxacillin.html
14. Chou CC, Shen CF, Chen SJ, Chen HM, Wang YC, et al; Infectious Diseases Society of Taiwan;; Taiwan Society of Pulmonary and Critical Care Medicine,; Medical Foundation in Memory of Dr. Deh-Lin Cheng;; Foundation of Professor Wei-Chuan Hsieh for Infectious Diseases Research and Education;; CY Lee's Research Foundation for Pediatric Infectious Diseases and Vaccines,; 4th Guidelines Recommendations for Evidence-based Antimicrobial agents use in Taiwan (GREAT) working group. Recommendations and guidelines for the treatment of pneumonia in Taiwan. J Microbiol Immunol Infect. 2019 Feb;52(1):172-199. doi: 10.1016/j.jmii.2018.11.004. Epub 2018 Dec 6. PMID: 30612923.